Pfizer ends deal with Pain Therapeutics to develop Durect's pain drug

Oct 27 (Reuters) - Pfizer Inc ended an agreement with Pain Therapeutics Inc to develop and market Durect Corp's pain drug, Remoxy, sending the stocks of the two smaller drugmakers plummeting.

from Reuters: Hot Stocks http://ift.tt/1rLq6Cc